Endometrial Cancer Treatment Market Analysis, Size, Share and Forecast to 2022

GLOBAL INDUSTRY INSIGHT: Endometrial Cancer Treatment Market Analysis, Size, Share, Development, Growth and Demand Forecast to 2022

Endometrial Cancer Treatment Market Analysis, Size, Share, Development, Growth and Demand Forecast to 2022

The global endometrial cancer treatment market is expected to witness growth due to unmet need of treatment, technological advancement in cancer therapeutics and diagnostic test, rising prevalence of cancer, and sedentary lifestyle of women. In addition, increasing awareness about the uterine diseases and the available therapies and increasing healthcare expenditure is also driving the growth of global endometrial cancer treatment market.

Explore

Report

at:

https://www.psmarketresearch.com/market-analysis/endometrial-cancer-

treatment-market The pharmaceutical companies are actively involved in the endometrial cancer research and development. AEterna Zentaris, Inc., is developing Zoptrex (zoptarelin doxorubicin), a Phase III clinical trial drug candidate for the treatment of endometrial cancer. In October 2016, the company entered into licensing agreement with Specialized Therapeutics Asia, a biopharmaceutical company, for the marketing of zoptarelin doxorubicin in Australia and New Zealand.

Endometrial cancer is an abnormal growth of uterus, in which inner lining of the uterus known as endometrium got affected. The American Cancer Society estimated that in year 2016, about 60,050 new cases of endometrial cancer would be diagnosed in the U.S. and about 10,470 women would die from cancers of the uterine body. The sign and symptoms of endometrial cancer is abnormal vaginal bleeding. It is most often diagnosed by pelvic ultrasound and transvaginal ultrasound. An endometrial biopsy is also preferred in postmenopausal women with endometrial cancer.

Request

for

Table

of

Content

at:

https://www.psmarketresearch.com/market-

analysis/endometrial-cancer-treatment-market/toc-sample Certain factors such as high treatment cost, low success rate of clinical trials, side effects of the treatment, high research and development expenditure, and lack of favorable government policy are the key factors hindering the growth of the global market during the forecast period.

Geographically, North America is expected to be the largest market for endometrial cancer treatment owing to the favorable healthcare infrastructure and government initiatives, increasing number of research and development activities, and high prevalence of endometrial cancer. The U.S. contributed largest revenue to the North American endometrial cancer treatment market and it is expected to remain the largest market globally, during the forecast period.

Browse

Other

Related

Report

at:

https://www.psmarketresearch.com/industry-

report/pharmaceuticals

Š P&S Market Research. All rights reserved

2

Endometrial Cancer Treatment Market Analysis, Size, Share, Development, Growth and Demand Forecast to 2022

Some of the key players operating in the global market are Bristol-Myers Squibb Company, Merck & Co., Inc., Ariad Pharmaceuticals Inc., GlaxoSmithKline plc, Novartis AG, Sanofi, Eisai Co., Ltd., Exelixis, Inc., F. Hoffmann-La Roche AG, and Abbott Laboratories.

About P&S Market Research P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.

With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact: Abhishek Executive – Client Partner 347, 5th Ave. #1402 New York City, NY - 10016 US/ Canada Toll-Free: 1-888-778-7886 Email: enquiry@psmarketresearch.com Web: https://www.psmarketresearch.com

Š P&S Market Research. All rights reserved

3